MENU
+Compare
PSIL
ETF ticker: NYSE ARCA
AS OF
Nov 13, 04:38 PM (EDT)
Price
$17.79
Change
-$1.05 (-5.57%)
Net Assets
18.93M

PSIL stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

PSIL
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for PSIL with price predictions
Nov 12, 2025

Momentum Indicator for PSIL turns negative, indicating new downward trend

PSIL saw its Momentum Indicator move below the 0 level on October 29, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 69 similar instances where the indicator turned negative. In of the 69 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for PSIL turned negative on October 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 32 similar instances when the indicator turned negative. In of the 32 cases the stock turned lower in the days that followed. This puts the odds of success at .

PSIL moved below its 50-day moving average on November 05, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PSIL crossed bearishly below the 50-day moving average on November 11, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PSIL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PSIL's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 54 cases where PSIL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PSIL advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

PSIL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 138 cases where PSIL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Market Cap

The average market capitalization across the AdvisorShares Psychedelics ETF ETF is 1.28B. The market cap for tickers in the group ranges from 597.41K to 14.64B. NBIX holds the highest valuation in this group at 14.64B. The lowest valued company is PBM at 597.41K.

High and low price notable news

The average weekly price growth across all stocks in the AdvisorShares Psychedelics ETF ETF was 49%. For the same ETF, the average monthly price growth was 102%, and the average quarterly price growth was 744%. RLMD experienced the highest price growth at 56%, while CMND experienced the biggest fall at -61%.

Volume

The average weekly volume growth across all stocks in the AdvisorShares Psychedelics ETF ETF was 48%. For the same stocks of the ETF, the average monthly volume growth was 104% and the average quarterly volume growth was -68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 43
P/E Growth Rating: 80
Price Growth Rating: 59
SMR Rating: 90
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)
View a ticker or compare two or three
PSIL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MiscellaneousSector

Profile
Fundamentals
Details
Category
Miscellaneous Sector
Address
AdvisorShares Trust Suite 7003 Bethesda Metro CenterBethesda
Phone
(202) 684-6383
Web
www.advisorshares.com